| Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin (NCT03043989) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-21 |
| Post-Operative Outcomes of Low Thermal Dissection vs. Traditional Electrosurgery (NCT03711916) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-17 |
| Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma (NCT02989636) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-10 |
| Trial of Mistletoe Extract in Patients With Advanced Solid Tumors (NCT03051477) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-01 |
| Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis (NCT03047135) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-01 |
| A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy (NCT03043807) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-02-22 |
| Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer (NCT02923180) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-02-14 |
| Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer (NCT02995330) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-02-09 |
| Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome (NCT02749708) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-01-30 |
| Markers for Predicting Risk of Breast Cancer in Women of Different Races (NCT02574546) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-01-01 |
| Image-Guided Gynecologic Brachytherapy (NCT02993900) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-12-15 |
| Perspectives on Bone Marrow Donors Who Donate for Their Parent (NCT03758911) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-12-06 |
| Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure (NCT02864316) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-12-01 |
| Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor (NCT02738866) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-10-25 |
| Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) (NCT02080195) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-09-13 |
| NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia (NCT02833805) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-09-01 |
| Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies (NCT05995821) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-08-25 |
| Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) (NCT02658981) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-08-24 |
| Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer (NCT02856100) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-08-03 |
| Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer (NCT02648282) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-07-18 |
| Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer (NCT02478125) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-07-01 |
| Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients (NCT02845297) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-07-01 |
| Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer (NCT02743910) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-07-01 |
| SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine (NCT02716948) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-23 |
| Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer (NCT02516670) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-20 |
| Head and Neck Cancer Treatment Related Dysphagia (NCT02657850) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-09 |
| Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer (NCT02825875) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-08 |
| A Study of Definitive Therapy to Treat Prostate Cancer (NCT02716974) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-01 |
| Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer. (NCT03497377) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-05-16 |
| Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer (NCT02452008) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-05-03 |
| Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors (NCT02644291) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-05-01 |
| Ultrasound Monitoring of Abdominal Soft Tissue (NCT02722616) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-05-01 |
| Stereotactic Body Radiation for Prostate Oligometastases (NCT02680587) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-04-28 |
| Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas (NCT02451982) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-03-28 |
| Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 (NCT02601014) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-03-15 |
| Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) (NCT02702960) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-03-01 |
| Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC (NCT02463799) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-02-22 |
| A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer (NCT02512172) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-02-19 |
| Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma (NCT02575222) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-02-01 |
| Vibrent Smartphone Mobile Application (NCT02421536) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-01-14 |
| Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma) (NCT02485990) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-01-08 |
| Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer (NCT02489357) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-12-11 |
| Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies (NCT02556931) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-12-01 |
| Simplifying Survivorship Care Planning (NCT03035773) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-10-01 |
| Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel (NCT02491411) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-09-01 |
| Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma (NCT02427893) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-08-01 |
| Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies (NCT02120157) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-07-02 |
| A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma (NCT02490930) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-07-01 |
| Utilizing Advance Care Planning Videos to Empower Perioperative Cancer Patients and Families (NCT02489799) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-07-01 |
| Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy (NCT02523924) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-06-02 |
| Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation (NCT02342613) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-28 |
| Evaluating the Effects of Psycho-oncological Education on Distress and Quality of Life in Solid Tumor Cancer Patients (NCT02370836) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| Survivorship Promotion In Reducing IGF-1 Trial (NCT02431676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy (NCT02203695) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-03-28 |
| FBnTP Imaging of Breast Cancer (NCT02204462) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-03-12 |
| A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer (NCT02396368) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-03-01 |
| Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (NCT02111174) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-03-01 |
| Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET (NCT03542773) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-02-06 |
| Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration (NCT02389738) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-02-01 |
| Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer (NCT02324543) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-02-01 |
| Patient and Provider Initiated Survivorship Care Planning (NCT02405819) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-02-01 |
| Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3) (NCT02354534) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-02-01 |
| Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation (NCT01958515) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-01-07 |
| GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab (NCT02243371) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-01-02 |
| Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance (NCT02286921) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-01-01 |
| Cancer DNA Detection in Blood and Urine (NCT02657863) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-11-01 |
| Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound (NCT02225925) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-10-01 |
| Reiki as a Complementary Therapy: A Pilot Study (NCT02207764) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-09-01 |
| Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC (NCT02259621) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-09-01 |
| Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer (NCT02215876) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-09-01 |
| RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) (NCT02090114) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-08-25 |
| Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia (NCT02224872) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-08-01 |
| Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma (NCT03843814) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-08-01 |
| Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme (NCT02177578) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-07-08 |
| Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors (NCT02080416) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-07-01 |
| Chemoradiation or Brachytherapy for Rectal Cancer (NCT02017704) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-06-12 |
| A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer (NCT02048384) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-06-10 |
| Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma (NCT01900496) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-06-01 |
| Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin (NCT02096588) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-05-20 |
| A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers (NCT02188563) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-05-01 |
| Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer (NCT02151760) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-05-01 |
| Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma (NCT01861340) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-05-01 |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) (NCT01966289) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-14 |
| A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer (NCT02111187) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer (NCT01784081) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy (NCT02115828) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| Red Cell Transfusion Goals in Patients With Acute Leukemias (NCT02086773) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance (NCT02146937) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-03-01 |
| Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer (NCT01937117) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-01-30 |
| Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine) (NCT01845805) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-01-10 |
| Stereotactic Body Radiation With Nelfinavir for Oligometastases (NCT01728779) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-01-08 |
| A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL (NCT02046694) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-01-06 |
| Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior (NCT01588951) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-12-01 |
| Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC. (NCT01928576) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-11-06 |
| Stereotactic Radiation Therapy for Pediatric Sarcomas (NCT01763970) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-11-01 |
| FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer (NCT01896869) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-11-01 |
| Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer (NCT01896856) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-10-23 |
| Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer (NCT01983709) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-10-01 |
| Tumor Motion Management in Radiotherapy Using 4D-MRI (NCT01934855) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-10-01 |
| IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins (NCT01939847) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-09-19 |